These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Not reported||2009-014527-23||Anidulafungin in patients with hematologic malignancies - An open-label, prospective study to evaluate the safety profile at prophylactic and therapeutic dosages||2011-09-30||due-trials|
|Listed as ongoing, but also has a completion date||2009-016994-13||EUropean Pharmacogenetics of AntiCoagulation Therapy trial||2013-03-25||bad-data|
|Ongoing||2016-004778-16||Carfilzomib in combination with lenalidomide and dexamethasone – feasibility and efficacy of a new consolidation regimen in inducing and/or re-inducing minimal residual disease negativity in multiple ...||not-yet-due|
|Ongoing||2016-004789-24||The Effect of Phosphate Lowering using sucroferric oxyhydroxide (PA21) on Calcification Propensity of Serum||not-yet-due|
|Ongoing||2018-000421-31||A study to investigate the influence of PTH-lowering by Etelcalcetide (Parsabiv®) on the Calcification Propensity of Serum in Dialysis Patients||not-yet-due|